FDA Inspection 543402 — Anderson & Collins Clinical Research Inc.

Anderson & Collins Clinical Research Inc. — FEI 2246602

The FDA completed an inspection of Anderson & Collins Clinical Research Inc. on October 21, 2008 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 21, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Edison, NJ (United States)

Additional Details

Clinical Investigator (CI)